SWA
MRNA icon

Stratos Wealth Advisors’s Moderna MRNA Stock Holding History

Stratos Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,592
Closed -$383K – 747
2024
Q1 		$383K Sell
3,592
-411
-10% -$41.4K 0.02% 512
2023
Q4 		$398K Buy
4,003
+978
+32% +$82.3K 0.02% 501
2023
Q3 		$312K Buy
+3,025
New +$337K 0.02% 520
2021
Q3 		– Sell
-948
Closed -$223K – 548
2021
Q2 		$223K Buy
+948
New +$169K 0.02% 496

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stratos Wealth Advisors's MRNA Position: Q2 2024 in Review

Stratos Wealth Advisors sold out of Moderna (MRNA) in Q2 2024, closing a stake of 3,592 shares — an estimated $383K sold.

Stratos Wealth Advisors first reported a position in MRNA in Q2 2021 and held it in 4 quarters. The position peaked at $398K in Q4 2023. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Stratos Wealth Advisors reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Stratos Wealth Advisors sold 3,592 Moderna shares in Q2 2024, an estimated $383K.
  • Stratos Wealth Advisors first reported a position in Moderna in Q2 2021 and held it in 4 quarters.
  • Stratos Wealth Advisors's Moderna position peaked at $398K in Q4 2023.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Stratos Wealth Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.